p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• Cancers frequently show elevated cyclin E, a key driver of genomic instability and tumorigenesis.
• Two critical tumor suppressor pathways, p53 and Fbw7, normally counteract cyclin E deregulation.
• Fbw7 targets cyclin E for degradation, and its mutations are common in cancers.

Purpose of the Study:

• To investigate the cooperative function of the p53 and Fbw7 pathways in suppressing cyclin E-driven genomic instability.
• To elucidate the combined roles of these pathways in maintaining genome stability in primary human cells.

Main Methods:

• Analysis of cyclin E activity and genomic instability in primary human cells with varying p53 and Fbw7 pathway status.
• Assessment of cell viability and apoptosis induction under conditions of impaired cyclin E degradation and p53/p21 function.

Main Results:

• Loss of both p53 and Fbw7 pathways synergistically exacerbates cyclin E-induced genomic instability.
• In p53-deficient cells, Fbw7 loss leads to persistent high cyclin E kinase activity, driving continuous instability.
• p21 is crucial for suppressing cyclin E when Fbw7 is impaired; its absence results in apoptosis due to sustained cyclin E activity.

Conclusions:

• The p53 and Fbw7 pathways act cooperatively to restrain cyclin E activity and prevent associated genomic instability.
• Disruption of both pathways creates a permissive environment for sustained cyclin E activity, promoting tumorigenesis.
• These findings highlight the critical interplay between p53 and Fbw7 in maintaining genome integrity against oncogenic cyclin E.